Objective: To provide a review on the use, percent positive agreement (PPA), percent negative agreement (PNA), and utilization of Syphilis Health Check for syphilis screening in community pharmacies (in coordination with public health departments) in an effort to increase overall syphilis screening in high-risk populations. Data Sources: PubMed was searched for the following keywords: syphilis, sexually transmitted diseases, diagnosis, public health, point-of-care tests. The search included all dates up to December 2016. Study Selection: Data from studies including the use of the Syphilis Health Check Rapid Immunochromatographic Test were included. Data Synthesis: There are many existing tests to aid in the diagnosis of syphilis. The Syphilis Health Check was compared with these assays using PPA and PNA, where it demonstrated a high level of accuracy in the detection of syphilis antibodies. Conclusion: The Syphilis Health Check Rapid Immunochromatographic Test is a Clinical Laboratory Improvement Amendments–waived assay that has been shown to be easy to use and produces results in minutes. As one of the most accessible health care providers, pharmacists have an opportunity to join the fight against syphilis, and in collaboration with public health departments, screen a vast number of high-risk patients and deliver follow-up care as needed.
SatterwhiteCLTorroneEMeitesE. Sexually transmitted infections among U.S. women and men: Prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40:187-193.
2.
Owusu-EduseiKJrChessonHWGiftTL. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis. 2013;40:197-201.
3.
Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2013. Atlanta, GA: US Department of Health and Human Services; 2014.
4.
HeffelfingerJDSwintEBBermanSMWeinstockHS.Trends in primary and secondary syphilis among men who have sex with men in the United States. Am J Public Health. 2007;97:1076-1083. doi:10.2105/AJPH.2005.070417.
5.
LukehartS. Syphilis. In: LongoDLFauciASKasperDLHauserSLLarry JamesonJLoscalzoJ, eds. Harrison’s Principles of Internal Medicine. 18th ed.New York, NY: McGraw-Hill Medical; 2011:1380-1388.
6.
RatnamS.The laboratory diagnosis of syphilis. Can J Infect Dis Med Microbiol. 2005;16:45-51.
Syphilis Health Check Rapid Immunochromatographic Test [Package insert].Stone Harbor, NJ: Diagnostics Direct; 2011.
12.
KlepserDGBisanzSEKlepserME.Cost-effectiveness of pharmacist provided treatment of adult pharyngitis. Am J Manag Care. 2012;18:e145-e154.
13.
GubbinsPOKlepserMEDering-AndersonAM. Point-of-care testing for infectious disease: opportunities, barriers, and considerations in community pharmacy. J Am Pharm Assoc (2003). 2014;54:163-71.
14.
Centers for Disease Control and Prevention. Recommendations for Public Health Surveillance of Syphilis in the United States. Atlanta, GA: US Department of Health and Human Services; March2003.
15.
Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2015. Morbidity and Mortality Weekly Report Recommendations and Reports. 2015;64:1-138.
